Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
10/19/1993 | US5254343 Applying salt of alpha-hydroxy acid |
10/19/1993 | CA1323374C 2 - furylbutyrolactones |
10/19/1993 | CA1323373C .beta.-d-phenyl-thioxylosides, their method of preparation and their useas therapeutics |
10/19/1993 | CA1323368C 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl] azetidines |
10/19/1993 | CA1323367C Phenyl-substituted piperidine compounds and their preparation and use in treating calcium overload in brain cells of mammals |
10/19/1993 | CA1323366C (1h-imidazol-1-ylmethyl) substituted benzimidazole derivatives |
10/19/1993 | CA1323365C Heterocyclic compounds and their preparation and use |
10/19/1993 | CA1323306C Pharmacological agent-lipid solution preparation |
10/19/1993 | CA1323305C Delivery systems for pharmacological agents |
10/18/1993 | CA2094219A1 Stabilized solid pharmaceutical preparation and method of producing the same |
10/18/1993 | CA2094164A1 Arylpiperidine derivative, process for the preparation thereof and pharmaceutical compositions containing it |
10/17/1993 | CA2094082A1 Substituted azetidinyle pyridone derivatives, antimicrobial agents |
10/17/1993 | CA2094076A1 Indole derivatives |
10/17/1993 | CA2094075A1 Indole derivatives |
10/17/1993 | CA2094073A1 Indole derivatives |
10/17/1993 | CA2093947A1 Propenoyl-imidazole derivatives |
10/17/1993 | CA2092342A1 Benzoxazinone and benzothiazinone derivatives endowed with cardiovascular activity |
10/16/1993 | CA2094117A1 Tachykinin receptor antagonists, isoquinolones and their production |
10/14/1993 | WO1993020438A1 A nicotine and/or nicotine metabolite detection system |
10/14/1993 | WO1993020221A1 Gene therapy using targeted viral vectors |
10/14/1993 | WO1993020101A1 Inhibitor of protein kinase c |
10/14/1993 | WO1993020100A1 Novel lipophilic oligopeptides with immunomodulating activity |
10/14/1993 | WO1993020097A1 17-substituted steroids useful in cancer treatment |
10/14/1993 | WO1993020095A1 Antisense oligonucleotide inhibition of papillomavirus |
10/14/1993 | WO1993020088A1 Mixed ligand metal complexes of nitric oxide-nucleophile adducts useful as cardiovascular agents |
10/14/1993 | WO1993020086A1 Process for producing derivatives of bis(aminomethyl) phosphinic acid |
10/14/1993 | WO1993020082A1 Calanolide antiviral compounds, compositions and uses thereof |
10/14/1993 | WO1993020080A1 Bridged bis-aryl carbinol derivatives, compositions and methods of use |
10/14/1993 | WO1993020078A1 Pharmaceutically active bicyclic-heterocyclic amines |
10/14/1993 | WO1993020076A1 Catalytic antibodies against cocaine and methods of using and producing same |
10/14/1993 | WO1993020073A1 Indole derivatives as 5-ht1 agonists |
10/14/1993 | WO1993020072A1 (furan-2-yl)-2-(1-normon-2-yl) oxazole derivatives with antibacterial activity |
10/14/1993 | WO1993020071A1 Substituted phenylcarbamates and phenylureas, their preparation and their use as 5-ht antagonists |
10/14/1993 | WO1993020066A1 Imidazole, triazole and tetrazole derivatives |
10/14/1993 | WO1993020063A1 Unbridged bis-aryl carbinol derivatives, compositions and methods of use |
10/14/1993 | WO1993020062A1 Process for the preparation of 4-pyridyl- and 4-piperidinylimidazoles useful as intermediates for the synthesis of histamine receptor antagonists |
10/14/1993 | WO1993020061A1 4-[4'-piperidinyl or 3'-pirrolidinyl] substituted imidazoles as h3-receptor antagonists and therapeutic uses thereof |
10/14/1993 | WO1993020059A1 Hydrazide derivatives of 3,4-dihydro-2h-1-benzopyrans |
10/14/1993 | WO1993020058A1 Novel cardioprotective agents |
10/14/1993 | WO1993020057A1 Novel derivatives of 2,3-dihydro-2,2,4,6,7-pentaalkyl-5-benzofuranols |
10/14/1993 | WO1993020056A1 Melamine derivatives for use in the treatment of cancer |
10/14/1993 | WO1993020055A1 Antiproliferative quinazolines |
10/14/1993 | WO1993020052A1 Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders |
10/14/1993 | WO1993020047A1 Hydroxamic acid based collagenase and cytokine inhibitors |
10/14/1993 | WO1993020046A1 Indan-1,3-dione and indan-1,2,3-trione derivatives, processes for preparation of same and their use as therapeutic agents |
10/14/1993 | WO1993020045A1 Indan-1,3-dione and indan-1,2,3-trione derivatives, processes for the preparation of same and their application as therapeutic agents |
10/14/1993 | WO1993020044A1 1,4 naphthoquinone derivtives with anti-protozoal and anti-parasitic activity |
10/14/1993 | WO1993020036A1 Total synthesis of taxol |
10/14/1993 | WO1993019778A1 Method for inducing tolerance to an antigen using butyrate |
10/14/1993 | WO1993019769A1 Wound healing and treatment of fibrotic disorders |
10/14/1993 | WO1993019768A1 Self-assembling polynucleotide delivery system |
10/14/1993 | WO1993019763A1 Rapamycin formulation for iv injection |
10/14/1993 | WO1993019762A1 Compositions for the treatment of infection and disease caused by hepatitis b virus (hbv) |
10/14/1993 | WO1993019761A1 Lipid-a analogs: new monosaccharide and disaccharide intermediates for eliciting therapeutic antibodies and for antitumor and antiviral activities |
10/14/1993 | WO1993019760A1 Method for inhibition of cell motility by sphingosine-1-phosphate, its derivatives and mimetics and method of synthesizing sphingosine-1-phosphate and its derivatives |
10/14/1993 | WO1993019759A1 Vitamin d derivative feed compositions and methods of use |
10/14/1993 | WO1993019758A1 Compositions and methods for treating benign prostatic hypertrophy |
10/14/1993 | WO1993019757A1 Use of phenothiazine derivatives for treating ischaemia and/or hypoxia |
10/14/1993 | WO1993019756A1 The use of quinoline-3-carboxamide compounds for treatment of diabetes |
10/14/1993 | WO1993019755A1 Medicament for the treatment of airways inflammation and airways hyperresponsiveness |
10/14/1993 | WO1993019754A1 Phenol and pyridinol derivatives as lusitropic agents |
10/14/1993 | WO1993019753A1 Parenteral solutions containing 3-dialkylaminoethoxybenzoyl-benzofurans |
10/14/1993 | WO1993019752A1 Inhibition of p70 s6 kinase |
10/14/1993 | WO1993019751A1 Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor |
10/14/1993 | WO1993019750A1 Compounds useful for treating allergic or inflammatory diseases |
10/14/1993 | WO1993019749A1 Compounds useful for treating allergic and inflammatory diseases |
10/14/1993 | WO1993019748A1 Compounds useful for treating inflammatory diseases and for inhibiting production of tumor necrosis factor |
10/14/1993 | WO1993019747A1 Compounds useful for treating allergic and inflammatory diseases |
10/14/1993 | WO1993019746A1 Topical administration of toremifene and its metabolites |
10/14/1993 | WO1993019745A1 Method of treating clostridium difficile colitis and cholera |
10/14/1993 | WO1993019744A1 External preparation for curing damage to skin |
10/14/1993 | WO1993019743A1 Method of treatment of hyperpigmentation in black skin with retinoic acid and method of lightening black skin with retinoic acid |
10/14/1993 | WO1993019742A1 Medicament against cardiac circulatory diseases |
10/14/1993 | WO1993019739A1 Viscous suspensions of controlled-release drug particles |
10/14/1993 | WO1993019737A1 A pharmaceutical composition containing a defined lipid system |
10/14/1993 | WO1993019736A1 A pharmaceutical carrier system containing defined lipids |
10/14/1993 | WO1993019730A1 Cosmetical or pharmaceutical compositions comprising deacylated glycerophospholipids for topical use |
10/14/1993 | WO1993019729A1 Retinoic acid as a skin tanning agent in persons of light skin color |
10/14/1993 | WO1993019720A2 Compounds |
10/14/1993 | WO1993019708A1 Transdermal albuterol absorption dosage unit and process |
10/14/1993 | WO1993019605A1 Evaluation and treatment of patients with progressive immunosuppression |
10/14/1993 | WO1993019591A1 Methods and compositions for gene, tumor, and viral infection therapy, and prevention of programmed cell death (apoptosis) |
10/14/1993 | WO1993015061A3 Method of preparing 2-arylbenzimidazole 5-sulphonic acids |
10/14/1993 | WO1992008456A3 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated |
10/14/1993 | DE4310051A1 Treating allergic rhinitis or conjunctivitis - using 3-substd. 6-(substd. phenyl)-pyridazine deriv., also for treating e.g. nasal polyps |
10/14/1993 | DE4310050A1 Use of sulphonamido:phenyl benzo:naphthyridine - for treating allergic rhinitis or conjunctivitis, and also for treating e.g. nasal polyps |
10/14/1993 | DE4212529A1 Verwendung von µ-Carbolinen als nicht-kompetitive Glutamat-Antagonisten Use of μ-carbolines as a non-competitive glutamate antagonists |
10/14/1993 | DE4212250A1 New 1-phenyl:benzyl -benzimidazole derivs. with alkylene-bridged heterocyclic gp. - used as angiotensin II antagonists e.g. for treating cardiovascular, pulmonary or CNS disorders |
10/14/1993 | DE4211878A1 Compsn. for treating multiple sclerosis - comprising protein, peptide or aminoacid with low glycine, glutamine, glutamic acid, arginine and phenylalanine content |
10/14/1993 | DE4211238A1 Topical treatment of skin or mucosal papillomatosis - using 2',5'- oligo:adenylate derivs. having strong activity against episomal papillome viruses |
10/14/1993 | CA2133744A1 1,4 naphthoquinone derivatives with anti-protozoal and anti-parasitic activity |
10/14/1993 | CA2133569A1 Novel lipophilic oligopeptides with immunomodulating activity |
10/14/1993 | CA2133470A1 Medicament for the treatment of airways inflammation and airways hyperresponsiveness |
10/14/1993 | CA2133461A1 4-[4'piperidinyl or 3'-pirrolidinyl] substituted imidazoles as h3-receptor antagonists and therapeutic uses thereof |
10/14/1993 | CA2133460A1 Process for the preparation of 4-pyridyl- and 4-piperidinylimidazoles useful as intermediates for the synthesis of histamine receptor antagonists |
10/14/1993 | CA2133440A1 Compositions and methods for treating benign prostatic hypertrophy |
10/14/1993 | CA2133415A1 A nicotine and/or nicotine metabolite detection system |
10/14/1993 | CA2133411A1 Gene therapy using targeted viral vectors |
10/14/1993 | CA2133193A1 Cosmetical or pharmaceutical compositions comprising deacylated glycerophospholipids for topical use |
10/14/1993 | CA2133083A1 Substituted phenylcarbamates and phenylureas, their preparation and their use as 5-ht antagonists |